Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs TXG✓SelectedUSD · TXGGSK vs TXG performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs TXG

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+68.4%
TXG return
+1.8%
Excess return
+66.6%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioTXGExcessAlpha
1D-0.1%-5.5%+5.4%+0.2%
7D-1.3%-15.5%+14.2%-0.5%
30D+2.7%-21.3%+24.0%+3.6%
3M+2.7%-2.0%+4.7%+2.1%
6M+3.3%+159.4%-156.1%-2.9%
YTD+6.5%+237.2%-230.7%-1.7%
1Y+10.7%+246.1%-235.4%+1.9%
3Y+64.4%+37.7%+26.7%+55.1%
5Y+46.7%-65.8%+112.5%+46.0%
All+68.4%+1.8%+66.6%+39.3%

Cumulative growth

Daily Returns

Daily percentage return beside TXG.

Daily Out/Under-Performance

Portfolio return minus TXG return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × TXG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded TXG wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling